Navigation Links
DoseCue(TM) Presents Positive Study Results at BioTech 2009
Date:11/16/2009

PHILADELPHIA, Nov. 16 /PRNewswire/ -- DoseCue, LLC announced this week that medication containers equipped with their automatic dose-time reminder devices significantly increase compliance, or adherence, according to results from a recent study.

The data, which were presented at BioTech 2009 in Philadelphia, showed that DoseCue electronic devices significantly improved patient compliance with oral-dose medications by 9.1%, without adding steps or changing the patient's dose-taking routine. In addition, overall compliance averaged 97.1% in the Study Group in Phase 2.

"This represents an important 'first'," stated DoseCue CEO, Mark Burrows. "The DoseCue trial is the first of its kind to achieve a statistically significant improvement in compliance using this one-of-a-kind, patented technology," he added, noting 95% Confidence Interval.

DoseCue's patented technology is integrated directly into manufacturers' current containers during filling and issues automatic reminder cues to patients when a medication needs to be dosed and signals when the dose has been taken. Electronics are integrated into the medication container itself, not the closure, to avoid mix-up and help differentiate the product.

The DoseCue study was conducted at a retail pharmacy to determine if patient compliance improved when oral-dose medications were dispensed in a DoseCue-equipped container. Thirty-five (35) patients were enrolled and randomized into either a Control or Study Group. All patients used an inactive container for Month 1 (Phase 1) which, unknown to participants, automatically logged date and time of open/close events, after which half were crossed-over to a container which also cued at dose time (Study Group). Remaining patients continued use of the inactive container (Control Group). Twenty-four (24) patients completed the study.

"We know the costs of non-compliance are high," said Burrows. "With DoseCue, there's no guesswork and compliance rates improve, resulting in better disease management, increased sales, and lower costs to the healthcare system."

DoseCue, LLC is a medication compliance company that integrates electronic dose-time reminder cues into manufacturers' existing factory-filled containers. These containers are clinically proven to increase compliance and remove the burden on patients to remember to take their oral-dose medication as prescribed by their physician.

www.dosecue.com

SOURCE DoseCue, LLC


'/>"/>
SOURCE DoseCue, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. Frontiers in Optics presents scientific advancements
2. New book presents successful strategies for probing genetic variation
3. NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research
4. New book presents methods to poke and prod individual molecules
5. Internationally recognized experts presents a complete overview on hydroecology and ecohydrology
6. Researcher helping to pioneer medical therapy for Fragile X Syndrome presents latest findings
7. ICS presents prestigious Digby McLaren Medal to Cincinnatis Carl Brett
8. Penn presents inaugural symposium on applied mathematics and computational science
9. Soil Science Society of America presents 2008 fellows
10. Soil Science Society of America presents awards in Houston
11. Arbor Vita presents new data on cancer diagnostic at EUrogin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2017)... Biomedical Research Institute announced that its Board of Trustees has ... Institute,s new President and CEO. Dr. Schlesinger will take the ... currently the Chair of the Department of Microbial Infection and ... at Ohio State University. "We are delighted to ... Texas Biomed," said Dr. James O. Rubin , Board ...
(Date:2/2/2017)... -- EyeLock LLC, a market leader of iris-based identity authentication ... You Should Know About Biometrics in the Cloud ."  ... a growing concern. In traditional schemes, cryptography is used ... schemes such as username/password suffer from inherent weaknesses. ... elegant solution to the problem of high-security user authentication. ...
(Date:1/31/2017)...  Spero Therapeutics, LLC, a biopharmaceutical company founded ... bacterial infections, today announced it has acquired a ... Bono Bio Ltd (PBB) to bolster its pipeline ... of Gram-negative bacteria.   The assets acquired have been ... group company. "The acquisition of these ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017  MIODx announced today that ... key immunotherapy technologies from the University of California, ... method to monitor a patient for response to ... CTLA-4.  The second license extends the technology with ... likely to have an immune-related adverse event (IRAE) ...
(Date:2/23/2017)... , ... February 23, 2017 ... ... announced today that in a published evaluation of multiple immunoassay-based threat detection ... Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found ...
(Date:2/23/2017)... , Feb. 23, 2017 Aviva Systems ... announced the acquisition of GenWay Biotech Incorporated, a ... service and product offering for both the research ... facilitate growth and enhance capabilities for both entities. GenWay,s ... ELISA assays will nicely complement ASB,s objective to ...
(Date:2/22/2017)... CA (PRWEB) , ... February 22, 2017 , ... ... a free AFM Luncheon for all SPIE attendees and Park ... CA, just one block from the San Jose Convention Center. The luncheon will ...
Breaking Biology Technology: